Varex Imaging price target lowered to $23 from $30 at Oppenheimer

Oppenheimer analyst Suraj Kalia lowered the firm’s price target on Varex Imaging (VREX) to $23 from $30 and keeps an Outperform rating on the shares following Q1 results and Q2 guidance. The firm believes that Varex remains a deep-value name, with best in-class X-ray core competency, a “sticky” end-user base, and call options on cold cathode technology and photon counting detectors, despite the near-term pressures.